SCHEMBL3874965

SCHEMBL3874965

Cc1cc2c(nc1C)c1cc(C)c(C)nc1c1cc(C)c(C)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 3/20 0.42
RAD52 P43351 2/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP1A2 P05177 2/20 0.39
GAA P10253 3/20 0.35
HTT P42858 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
MAPT P10636 2/20 0.33
NQO2 P16083 1/20 0.33
RAB9A P51151 1/20 0.31
QRFPR Q96P65 1/20 0.31
CCR1 P32246 1/20 0.31
CCR8 P51685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17123347 0.79 KDM4E (0.38) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL29986530 0.79 GPR3 (0.42) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL31275382 0.79 GPR3 (0.42) KDM4ESMN1; SMN2ALDH1A1CYP1A2GAA
SCHEMBL20412811 0.76 CCR1 (0.37) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL13197743 0.74 NQO2 (0.37) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL15460375 0.74 CCR1 (0.43) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL27899723 0.74 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL694204 0.74 NOS3 (0.41) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL3947268 0.73 KDM4E (0.45) KDM4ESMN1; SMN2ALDH1A1RAD52POLB
SCHEMBL14214187 0.71 NPC1 (0.50) KDM4ESMN1; SMN2ALDH1A1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom LRBA, CD74, BMP2 KDM4E 4789/4885SMN1; SMN2 4591/4885ALDH1A1 2995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.